Rani Therapeutics Holdings Stock Price on October 17, 2024
| RANI Stock | USD 1.99 0.04 2.05% |
If you're considering investing in Rani Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rani Therapeutics stands at 1.99, as last reported on the 28th of November, with the highest price reaching 2.03 and the lowest price hitting 1.95 during the day. Rani Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0323, which implies the firm had a -0.0323% return per unit of risk over the last 3 months. Rani Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rani Therapeutics' Risk Adjusted Performance of (0.02), coefficient of variation of (2,907), and Variance of 97.61 to confirm the risk estimate we provide.
As of now, Rani Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Rani Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 86.4 M, while Common Stock Shares Outstanding is projected to decrease to under 23.9 M. . As of now, Rani Therapeutics' Price Book Value Ratio is increasing as compared to previous years. The Rani Therapeutics' current Price To Book Ratio is estimated to increase to 6.91, while Price To Sales Ratio is projected to decrease to 129.59. Rani Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Rani |
Sharpe Ratio = -0.0323
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RANI |
Estimated Market Risk
| 9.79 actual daily | 87 87% of assets are less volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rani Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rani Therapeutics by adding Rani Therapeutics to a well-diversified portfolio.
Price Book 21.2468 | Enterprise Value Ebitda (1.42) | Price Sales 313.1706 | Shares Float 20.4 M | Wall Street Target Price 11.5 |
Rani Therapeutics Main Headline on 17th of October 2024
Rani Therapeutics Announces New Preclinical Pharmacokinetic ... by finance.yahoo.com
-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous injection - - New pharmacokinetic data provides further evidence of the RaniPill platforms potential to enable oral delivery of multiple obesity treatments - - Phase 1 study for RT-114, an oral GLP-1GLP-2 dual agonist for the treatment of obesity, expected to initiate in 2025 - SAN JOSE, Calif., Oct.
Rani Therapeutics Valuation on October 17, 2024
It is possible to determine the worth of Rani Therapeutics on a given historical date. On October 17, 2024 Rani was worth 2.75 at the beginning of the trading date compared to the closed value of 2.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rani Therapeutics stock. Still, in general, we apply an absolute valuation method to find Rani Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rani Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rani Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.35 | 2.90 | 2.35 | 2.60 | 8,404,808 | |
10/17/2024 | 2.75 | 2.81 | 2.50 | 2.63 | 2,579,534 |
| 2.64 | 2.78 | 2.55 | 2.68 | 1,828,110 |
| Backtest Rani Therapeutics | | | Rani Therapeutics History | | | Rani Therapeutics Valuation | Previous | Next |
Rani Therapeutics Trading Date Momentum on October 17, 2024
| On October 18 2024 Rani Therapeutics Holdings was traded for 2.68 at the closing time. The top price for the day was 2.78 and the lowest listed price was 2.55 . The trading volume for the day was 1.8 M. The trading history from October 18, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 1.90% . The trading delta at closing time against the current closing price is 8.37% . |
Rani Therapeutics Fundamentals Correlations and Trends
By evaluating Rani Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rani Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rani financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rani Therapeutics Stock history
Rani Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rani is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rani Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rani Therapeutics stock prices may prove useful in developing a viable investing in Rani Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.5 M | 23.9 M | |
| Net Loss | -55.1 M | -52.3 M |
Rani Therapeutics Quarterly Net Working Capital |
|
Rani Therapeutics Stock Technical Analysis
Rani Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rani Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Rani Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rani Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Rani Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rani Therapeutics shares will generate the highest return on investment. By undertsting and applying Rani Therapeutics stock market strength indicators, traders can identify Rani Therapeutics Holdings entry and exit signals to maximize returns
Rani Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rani Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Rani Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rani to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.70) | |||
| Total Risk Alpha | (1.84) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Rani Stock analysis
When running Rani Therapeutics' price analysis, check to measure Rani Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rani Therapeutics is operating at the current time. Most of Rani Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rani Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rani Therapeutics' price. Additionally, you may evaluate how the addition of Rani Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |